REFERENCES
1.Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease
and the risks of death, cardiovascular events, and hospitalization. N
Engl J Med. 2004 Sep 23;351(13):1296-305. doi: 10.1056/NEJMoa041031.
Erratum in: N Engl J Med. 2008;18(4):4. PMID: 15385656.
2. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease.
Lancet. 2017 Mar 25;389(10075):1238-1252
3. Al-Lamee RK, Nowbar AN, Francis DP. Percutaneous coronary
intervention for stable coronary artery disease. Heart. 2019
Jan;105(1):11-19. doi: 10.1136/heartjnl-2017-312755.
4. Parikh PB, Bhatt DL, Bhasin V, Anker SD, Skopicki HA, Claessen BE,
Fonarow GC, Hernandez AF, Mehran R, Petrie MC, Butler J. Impact of
Percutaneous Coronary Intervention on Outcomes in Patients With Heart
Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 May
18;77(19):2432-2447.
5. Akbari T, Al-Lamee R. Percutaneous Coronary Intervention in
Multi-Vessel Disease. Cardiovasc Revasc Med. 2022 Nov;44:80-91.
6. Wu W, Gao M, Wu X. A Systematic Review and Meta-Analysis of
Influences of Chronic Kidney Disease on Patients after Percutaneous
Coronary Intervention for Chronic Total Occlusions. Comput Math Methods
Med. 2023 Feb 22;2023:9450752.
7. Bangalore S, Maron DJ, Fleg JL, O’Brien SM, Herzog CA, Stone GW, Mark
DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman
JS; ISCHEMIA-CKD Research Group. International Study of Comparative
Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney
Disease (ISCHEMIA-CKD): Rationale and design. Am Heart J. 2018
Nov;205:42-52. doi: 10.1016/j.ahj.2018.07.023. Epub 2018 Aug 1. PMID:
30172098; PMCID: PMC6283671.
8. Holzmann MJ, Siddiqui AJ. Outcome of Percutaneous Coronary
Intervention During Non-ST-Segment-Elevation Myocardial Infarction in
Elderly Patients With Chronic Kidney Disease. J Am Heart Assoc. 2020 Jun
16;9(12):e015084.
9. Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Morawiec B,
Dola J, Gładysz S, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska
E, Wojakowski W. Long-Term Percutaneous Coronary Intervention Outcomes
of Patients with Chronic Kidney Disease in the Era of Second-Generation
Drug-Eluting Stents. Cardiorenal Med. 2017 Feb;7(2):85-95.
10. Claessen BEPM, Kikkert WJ, Hoebers LP, Bahadurzada H, Vis MM, Baan
J, Koch KT, de Winter RJ, Tijssen JGP, Piek JJ, Henriques JPS. Long-term
ischaemic and bleeding outcomes after primary percutaneous coronary
intervention for ST-elevation myocardial infarction in the elderly. Neth
Heart J. 2015 Sep;23(10):477-482.
11.Harenberg J, Hentschel VA, Du S, Zolfaghari S, Krämer R, Weiss C,
Krämer BK, Wehling M. Anticoagulation in patients with impaired renal
function and with haemodialysis. Anticoagulant effects, efficacy,
safety, therapeutic options. Hamostaseologie. 2015;35(1):77-83. doi:
10.5482/HAMO-14-08-0036. Epub 2014 Nov 18. PMID: 25405246.
12. Limpijankit T, Chandavimol M, Srimahachota S, Kanoksilp A,
Jianmongkol P, Siriyotha S, Thakkinstian A, Buddhari W, Sansanayudh N.
Dose-dependent effect of impaired renal function on all-cause mortality
in patients following percutaneous coronary intervention. Clin Cardiol.
2022 Aug;45(8):882-891. doi: 10.1002/clc.23877. Epub 2022 Jun 27. PMID:
35758306; PMCID: PMC9346964.
13. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM.
Grade of chronic renal failure, and acute and long-term outcome after
percutaneous coronary interventions. Kidney Int. 2003 Feb;63(2):696-701.
14. Barthelemy O, Helft G, Silvain J, Bellemain-Appaix A, Beygui F,
Choussat R, Berman E, Collet JP, Montalescot G, Metzger JP, Le Feuvre C.
One-year clinical outcomes in patients with chronic renal failure
treated by percutaneous coronary intervention with drug-eluting stent.
Arch Cardiovasc Dis. 2011 Dec;104(12):604-10.
15. Limpijankit T, Chandavimol M, Srimahachota S, Kanoksilp A,
Jianmongkol P, Siriyotha S, Thakkinstian A, Buddhari W, Sansanayudh N.
Dose-dependent effect of impaired renal function on all-cause mortality
in patients following percutaneous coronary intervention. Clin Cardiol.
2022 Aug;45(8):882-891.
16. Lee JM, Kang J, Lee E, Hwang D, Rhee TM, Park J, Kim HL, Lee SE, Han
JK, Yang HM, Park KW, Na SH, Kang HJ, Koo BK, Kim HS. Chronic Kidney
Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis
of the Korean Multicenter Drug-Eluting Stent Registry. JACC Cardiovasc
Interv. 2016 Oct 24;9(20):2097-2109.
17. Tasoudis PT, Varvoglis DN, Tzoumas A, Doulamis IP, Tzani A, Sá MP,
Kampaktsis PN, Gallo M. Percutaneous coronary intervention versus
coronary artery bypass graft surgery in dialysis-dependent patients: A
pooled meta-analysis of reconstructed time-to-event data. J Card Surg.
2022 Oct;37(10):3365-3373.
18. Pilmore H, Webster M, Sidhu K, Srikumar G. Management of coronary
artery disease in patients on dialysis. N Z Med J. 2017 Dec
15;130(1467):11-22.
19. Choi HY, Park HC, Ha SK. How do We Manage Coronary Artery Disease in
Patients with CKD and ESRD? Electrolyte Blood Press. 2014
Dec;12(2):41-54.
20. Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y. Coronary artery
bypass grafting vs. drug-eluting stent implantation in patients with
end-stage renal disease requiring dialysis. Ren Fail. 2020
Nov;42(1):107-112.
21. Jerkic H, Letilovic T, Stipinovic M, Pocanic D, Catic J, Knotek M.
Association of chronic kidney disease with periprocedural myocardial
injury after elective stent implantation: A single center prospective
cohort study. Medicine (Baltimore). 2016 Nov;95(45):e5381. doi:
10.1097/MD.0000000000005381. PMID: 27828870; PMCID: PMC5106076..
22. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy
with volume expansion. Clin J Am Soc Nephrol. 2008;3(1):273–280.
23. McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM,
Vallabahn RC, Mehta A. Contrast-induced acute kidney injury. J Am Coll
Cardiol. 2016;68(13):1465–1473.
24. Yager N, Hongalgi K, Torosoff M. Chronic Kidney Disease and
Post-Percutaneous Coronary Intervention Mortality in Patients With Left
Main and Equivalent Coronary Artery Disease. Tex Heart Inst J. 2022 Sep
1;49(5):e217670.
25. Dennis I Narcisse 1, Elizabeth Hope Weissler 2 3 4, Jennifer A Rymer
1 2, Ehrin J Armstrong 5, Eric A Secemsky 6, William A Gray 7, Jihad A
Mustapha 8, George L Adams 9, Gary M Ansel 10, Manesh R Patel 1 2,
William Schuyler Jones 1 2. The impact of chronic kidney disease on
outcomes following peripheral vascular intervention. Clin Cardiol. 2020
Nov;43(11):1308-1316. doi: 10.1002/clc.23444. Epub 2020 Aug 11.
26. Jingwen Yong 1, Jinfan Tian 1, Xin Zhao 1, Xueyao Yang 1, Haoran
Xing 1, Yi He 2, Xiantao Song 3. Optimal treatment strategies for
coronary artery disease in patients with advanced kidney disease: a
meta-analysis. Ther Adv Chronic Dis. 2021 Jul 7;12:20406223211024367.
doi: 10.1177/20406223211024367. eCollection 2021.
27. Brijesh Patel 1, Mahek Shah 1, Raman Dusaj 1, Sharon Maynard 1,
Nainesh Patel 1. Percutaneous coronary intervention and inpatient
mortality in patients with advanced chronic kidney disease presenting
with acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017
Oct;30(4):400-403. doi: 10.1080/08998280.2017.11930205.
28. Ali ZA, Escaned J, Dudek D, Radhakrishnan J, Karimi Galougahi K.
Strategies for Renal Protection in Cardiovascular Interventions. Korean
Circ J. 2022 Jul;52(7):485-495. doi: 10.4070/kcj.2022.0093. PMID:
35790493; PMCID: PMC9257153.
29. Kumar, Prathap & Jino, Blessvin & Shafeeq, Ali & Roy, Stalin &
Rajendran, Manu & Villoth, Sandheep George. (2021). IVUS-Guided
Zero-Contrast PCI in CKD Patients: Safety and Short-Term Outcome in
Patients with Complex Demographics and/or Lesion Characteristics.
Journal of Interventional Cardiology. 2021. 1-7. 10.1155/2021/6626749.
30. Caracciolo A, Scalise RFM, Ceresa F, Bagnato G, Versace AG,
Licordari R, Perfetti S, Lofrumento F, Irrera N, Santoro D, Patanè F, Di
Bella G, Costa F, Micari A. Optimizing the Outcomes of Percutaneous
Coronary Intervention in Patients with Chronic Kidney Disease. J Clin
Med. 2022 Apr 23;11(9):2380. doi: 10.3390/jcm11092380. PMID: 35566504;
PMCID: PMC9100167.
Table 1: Baseline characteristics of study population